Showing 1 - 6 results of 6 for search ', S. A. Holstein', query time: 0.02s
Refine Results
-
1
Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma by Staci L. Haney, Sarah A. Holstein
Published 2022-12-01
Article -
2
-
3
Future Directions in Maintenance Therapy in Multiple Myeloma by Sarah A. Holstein, Vera J. Suman, Jens Hillengass, Philip L. McCarthy
Published 2021-05-01
Article -
4
S181: MODAKAFUSP ALFA (TAK-573): UPDATED CLINICAL, PHARMACOKINETIC (PK), AND IMMUNOGENICITY RESULTS FROM A PHASE 1/2 STUDY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELO... by J. L. Kaufman, S. Atrash, , S. A. Holstein, O. Nadeem, D Benson, K. Suryanarayan, Y. Liu, C. Li, L. Yang, X. Parot, D. T. Vogl
Published 2022-06-01
Article -
5
PB2129: THE MODAKAFUSP ALFA IINNOVATE CLINICAL DEVELOPMENT PROGRAM: RATIONALE AND DESIGN OF 3 PHASE 1/2 TRIALS OF AN INNATE IMMUNITY ENHANCER FOR MULTIPLE MYELOMA (MM) by Sarah A. Holstein, Hira Mian, Cyrille Touzeau, Edwin Kingsley, Dan Vogl, Richard Zuniga, Kaveri Suryanarayan, Shining Wang, Laura Thesillat-Versmee, Yuyin Liu, Tian Chen, Yefei Zhang, Xavier Parot, Hans C. Lee
Published 2023-08-01
Article -
6
The Peptide–Drug Conjugate Melflufen Modulates the Unfolded Protein Response of Multiple Myeloma and Amyloidogenic Plasma Cells and Induces Cell Death by Ken Flanagan, Romika Kumari, Juho J. Miettinen, Staci L. Haney, Michelle L. Varney, Jacob T. Williams, Muntasir M. Majumder, Minna Suvela, Ana Slipicevic, Fredrik Lehmann, Nina N. Nupponen, Sarah A. Holstein, Caroline A. Heckman
Published 2022-03-01
Article